Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caleb K Stein

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
BMC Bioinformatics|April 19, 2015
Removing batch effects from purified plasma cell gene expression microarrays with modified ComBatCaleb K Stein, Pingping Qu, Joshua Epstein, et al.
Blood|August 27, 2025
An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burdenErin W Meermeier, Kirsten Pfeffer, Caleb K Stein, et al.
Blood Cancer Discovery|September 21, 2020
Monosomic loss of MIR15A/MIR16-1 is a driver of multiple myeloma proliferation and disease progressionMarta Chesi, Caleb K Stein, Victoria M Garbitt, et al.
Cancer Research Communications|June 11, 2026
Clinical evaluation of ex vivo expanded MUC1-specific peripheral blood T Cells for adoptive immunotherapy in relapsed/refractory multiple myelomaErin W Meermeier, Dara S Missan, Latha B Pathangey, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
The Vk*MYC Mouse Model recapitulates human multiple myeloma evolution and genomic diversityFrancesco Maura, David G Coffey, Caleb K Stein, et al.
Nature Communications|May 7, 2024
The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humansFrancesco Maura, David G Coffey, Caleb K Stein, et al.
Oncotarget|April 22, 2017
The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myelomaCaleb K Stein, Charlotte Pawlyn, Shweta Chavan, et al.
NPJ Precision Oncology|April 14, 2026
Proteomic profiling revealed unique disease biology associated with 1q abnormalities in multiple myelomaKiran K Mangalaparthi, Joel-Sean Hsu, J Erin Wiedmeier-Nutor, et al.
Blood Cancer Discovery|July 14, 2021
Tumor burden limits bispecific antibody efficacy through T cell exhaustion averted by concurrent cytotoxic therapyErin W Meermeier, Seth J Welsh, Meaghen E Sharik, et al.
Blood Cancer Discovery|November 7, 2023
ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple MyelomaPaola Neri, Benjamin G Barwick, David Jung, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
BMC Bioinformatics|April 19, 2015
Removing batch effects from purified plasma cell gene expression microarrays with modified ComBatCaleb K Stein, Pingping Qu, Joshua Epstein, et al.
Blood|August 27, 2025
An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burdenErin W Meermeier, Kirsten Pfeffer, Caleb K Stein, et al.
Blood Cancer Discovery|September 21, 2020
Monosomic loss of MIR15A/MIR16-1 is a driver of multiple myeloma proliferation and disease progressionMarta Chesi, Caleb K Stein, Victoria M Garbitt, et al.
Cancer Research Communications|June 11, 2026
Clinical evaluation of ex vivo expanded MUC1-specific peripheral blood T Cells for adoptive immunotherapy in relapsed/refractory multiple myelomaErin W Meermeier, Dara S Missan, Latha B Pathangey, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
The Vk*MYC Mouse Model recapitulates human multiple myeloma evolution and genomic diversityFrancesco Maura, David G Coffey, Caleb K Stein, et al.
Nature Communications|May 7, 2024
The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humansFrancesco Maura, David G Coffey, Caleb K Stein, et al.
Oncotarget|April 22, 2017
The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myelomaCaleb K Stein, Charlotte Pawlyn, Shweta Chavan, et al.
NPJ Precision Oncology|April 14, 2026
Proteomic profiling revealed unique disease biology associated with 1q abnormalities in multiple myelomaKiran K Mangalaparthi, Joel-Sean Hsu, J Erin Wiedmeier-Nutor, et al.
Blood Cancer Discovery|July 14, 2021
Tumor burden limits bispecific antibody efficacy through T cell exhaustion averted by concurrent cytotoxic therapyErin W Meermeier, Seth J Welsh, Meaghen E Sharik, et al.
Blood Cancer Discovery|November 7, 2023
ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple MyelomaPaola Neri, Benjamin G Barwick, David Jung, et al.
Pageof 2